Long-term testosterone may result in remission of diabetes in men with hypogonadism
According to a study presented June 23, 2018 at the American Diabetes Association 2018 Scientific Sessions in Orlando, Florida, long-term administration of testosterone may result in remission of diabetes in some men with hypogonadism. In the study, 22% of men with type 2 diabetes and hypogonadism had diabetes remission after 10 years of testosterone injections every 3 months.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies